Miscellaneous

The CenterWatch Monthly, March 2012

Thursday, March 1, 2012 06:05 AM

Living in a post-M&A world of CROs

More... »

U.K. unemployment: the case for optimism

Thursday, March 1, 2012 06:01 AM

Dr. John Philpott, chief economic adviser at the Chartered Institute of Personnel and Development (CIPD), told the Yorkshire HR Directors Forum in Leeds on February 29 that even a relatively modest economic recovery in 2012 could see U.K. unemployment stabilize at around the current rate of 8.4%, while a stronger recovery has the potential to result in a sudden sharp fall in the jobless total.

More... »

Multiple Myeloma Research Foundation’s Edward Jay Phillips deceased

Monday, April 11, 2011 12:31 PM

The Multiple Myeloma Research Foundation (MMRF) mourns the loss of board member Edward (“Eddie”) Jay Phillips, who, on April 8, 2011 died of multiple myeloma. Phillips, son of "Dear Abby" and creator of Belvedere Vodka, had battled multiple myeloma for nine years.

More... »

Thomas Littlejohn will be remembered for his innovation, spirit and desire to give back

Monday, April 11, 2011 03:07 AM

It’s the laughter that the staff of site group PMG Research say they will miss the most about Thomas W. Littlejohn III. His was a baritone laugh that could often be heard booming down the hallway at any of PMG’s 11 sites, usually accompanied by knee slapping and, if you were in the room with him, a jolly red face.

More... »

EMA seeks public comment on biomarker

Wednesday, March 2, 2011 01:49 PM

The European Medicines Agency (EMA) is seeking public comment on the first clinical biomarker the agency has approved for use in humans, according to a report in PharmaTimes.

More... »

The CenterWatch Monthly February 2011

Thursday, February 3, 2011 01:08 PM

The High Cost and Questionable Impact of 100% SDV 

More... »

The CenterWatch Monthly December 2010

Monday, November 29, 2010 12:30 PM

Pessimism and instability defining the clinical research workforce

More... »

ProPublica report: big pharma paid hundreds of physicians over $100,000 in speaking fees

Monday, November 8, 2010 11:12 AM

Several doctors paid to speak on behalf of big pharmaceutical companies aren’t, in fact, the thought leaders consumers often consider them to be, but instead have been sanctioned for various forms of misconduct. And psychiatrists collect more in speaking and consulting fees from pharma companies than doctors in any other specialty.

More... »

NIH official sees need to evaluate effectiveness of IRBs in protecting study volunteers

Monday, October 18, 2010 07:40 AM

Institutional Review Boards (IRBs) are central to the system of protecting human subjects who participate in clinical research, yet concerns have been raised that there is no way to measure whether IRBs actually do their job of protecting study volunteers from unnecessary risk of harm.

More... »

The CenterWatch Monthly October 2010

Friday, October 1, 2010 09:04 AM

Anticipating disruptions from sponsor M&As and consolidations

More... »